This isn't a story of drug company overreach, it's about how your government has driven the costs of compliance so high that it's not worth making a drug unless

This isn't a story of drug company overreach, it's about how your government has driven the costs of compliance so high that it's not worth making a drug unless you can extract monopoly rent from it. The drug (pyrimethamine) has been in the public domain for more than 30 years, but in the US the government imposed costs mean that it wasn't (until now) worthwhile for another manufacturer to go through the process of US certification for such a low volume, low margin drug. You can buy pyrimethamine for $0.10 a tablet in most of the rest of the world, but that's not thanks to the power of socialised medicine. It's because of less onerous government regulation that means you can manufacture your drug for $0.10, comply with regulations and still turn a profit.